Immune Biosolutions

[{"orgOrder":0,"company":"Immune Biosolutions","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"IBIO123","moa":"Unknown","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Immune Biosolutions","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Immune Biosolutions \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Immune Biosolutions \/ Undisclosed"},{"orgOrder":0,"company":"Immune Biosolutions","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"IBIO123","moa":"Unknown","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Immune Biosolutions","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Immune Biosolutions \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Immune Biosolutions \/ Undisclosed"},{"orgOrder":0,"company":"Immune Biosolutions","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"IBIO123","moa":"Unknown","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Immune Biosolutions","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Immune Biosolutions \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Immune Biosolutions \/ Undisclosed"}]